About Glamorous AI
Glamorous AI is a company based in London (United Kingdom) founded in 2020 was acquired by X-Chem in October 2021. Glamorous AI offers products and services including DEL Screening, ReadiDEL, ReadiBLOX, ArtemisAI, and HITMiner. Glamorous AI operates in a competitive market with competitors including GenOway, TransCure bioServices, InVivo Biosystems, PsychoGenics and PharmaLegacy Laboratories, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Glamorous AI
Glamorous AI offers a comprehensive portfolio of products and services, including DEL Screening, ReadiDEL, ReadiBLOX, ArtemisAI, and HITMiner.
Screening platform for identifying small molecule hits using DNA libraries.
Pre-built library for rapid drug discovery applications.
Modular blocks for custom medicinal chemistry synthesis.
AI tool for analyzing molecular interactions in drug discovery.
Platform for mapping compounds and expanding hits in research.
Funding Insights of Glamorous AI
Detailed funding history for Glamorous AI
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Glamorous AI
Glamorous AI has secured backing from 1 investor. Prominent investors backing the company include X-Chem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Small molecule drug discovery platform is provided to researchers.
|
Locked | Locked | Locked |
Investor details for Glamorous AI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Glamorous AI
Investment portfolio details for Glamorous AI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Glamorous AI
Detailed financials for Glamorous AI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Glamorous Ai Comparisons
Peer comparison for Glamorous AI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Glamorous AI
Glamorous AI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenOway, TransCure bioServices, InVivo Biosystems, PsychoGenics and PharmaLegacy Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| Locked | Locked | Locked |
Humanized mouse models are developed for preclinical immune drug studies.
|
|
| Locked | Locked | Locked |
Animal models are supplied for in-vivo analytical services.
|
|
| Locked | Locked | Locked |
Preclinical CRO services for CNS and orphan disorders are offered.
|
|
| Locked | Locked | Locked |
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
|
|
| Locked | Locked | Locked |
Preclinical contract research organization offering standard GLP and non-GLP services
|
Detailed competitors of Glamorous AI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Glamorous Ai
Complete news archive for Glamorous AI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glamorous AI
Glamorous AI was founded in 2020.
Glamorous AI is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Glamorous AI was founded in 2020 and is based in London, United Kingdom. Operations focus on the biopharma sector, where preclinical studies are conducted to support drug discovery processes. Services include analysis and testing in early-stage research, aiding pharmaceutical companies in development pipelines. The company maintains a domain at glamorous.ai for its digital presence.
Glamorous AI's top competitors include GenOway, PsychoGenics and PharmaLegacy Laboratories.
Glamorous AI offers DEL Screening, ReadiDEL, ReadiBLOX, ArtemisAI, and HITMiner.
Glamorous AI has 1 investor. Key investors include X-Chem.